Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9504672
APP PUB NO 20150209328A1
SERIAL NO

14683935

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MICRODOSE THERAPEUTX, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cook, Robert O Hillsborough, US 31 481
Reynolds, Eugene R Scotch Plains, US 3 660
Shekunov, Boris Hillsborough, US 2 2
Zegar, Siead I Orland Park, US 4 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 29, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 29, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00